Loading clinical trials...

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia | Clinical Trials | Clareo Health

COMPLETEDNA

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia: A Randomized Controlled Trial

NCT05841329•Shanghai Mental Health Center

Summary

The goal of this clinical trial is to examine whether transcranial direct current stimulation(tDCS) can enhance the effect of virtual reality exposure therapy(VRET) in acrophobia in college students with significant fear of heights. The main question it aims to answer are: • the enhancement of tDCS on the effect of VRET Participants will randomly allocated to tDCS active stimulated group and sham stimulated group and receive VRET.

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•the score of the AQ-Anxiety had to be at least 45.45(1SD below the mean of a previous acrophobia sample(Cohen, 1977));
•the participants had the avoidance behaviors in daily life and recognized the fear of height was excessive and unnecessary (the severity of fear of heights not less than 5 points at a scale from 0 to 10).

Exclusion Criteria

•previous treatment for acrophobia, history or family history of any mental disorder (except for acrophobia), metal parts in the head, medical implants, increased intracranial pressure, pregnancy, current involvement in psycho- or pharmacotherapy, and cardiovascular or neurological diseases.

Locations (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

Key Dates

Start Date

August 6, 2020

Primary Completion Date

July 15, 2021

Completion Date

July 15, 2021

Last Updated

May 3, 2023

Enrollment

ACTUAL participants

Conditions

AcrophobiaTranscranial Direct Current Stimulation

Interventions

tDCS

DEVICE

virtual reality exposure therapy

BEHAVIORAL

Resting-State Functional Connectivity as a Predictor of tDCS Effects in Adolescents With Autism Spectrum Disorder

NCT06878326

Autism Spectrum Disorder (ASD)Transcranial Direct Current Stimulation (tDCS)+1 more

View study

RECRUITINGNA

High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease

NCT04599764

Transcranial Direct Current StimulationFunctional Magnetic Resonance Imaging+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia

Inclusion Criteria

Exclusion Criteria

Resting-State Functional Connectivity as a Predictor of tDCS Effects in Adolescents With Autism Spectrum Disorder

High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease

fMRI Analysis of Aging and Awareness in Conditioning

Intervention Effect of High Definition Transcranial Direct Current Stimulation (HD-tDCS) on Depressive Disorder

Clinical Efficacy and Mechanism of High Definition tDCS Based on dmPFC in the Intervention of Chronic Insomnia

Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic